---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-24-001750"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:47:28.979996+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Renovaro amends consulting agreement with Interim CFO Simon Tarsh; $25k/month plus options

## Summary
- Simon Tarsh continues as Interim CFO under amended agreement; monthly fee $25,000.
- Tarsh received $29,063 bonus on Oct 31 and will receive another $29,063 on Nov 30.
- Granted 58,500 stock options under 2023 Equity Incentive Plan; vest if new CFO hired before termination.
- Agreement term is 3 months, renewable monthly; either party may terminate on 30 days notice.
- Tarsh eligible for target bonus up to 30% of total consideration if milestones achieved (timely SEC filings and new CFO).

## SEC filing metadata
- accession: 0001731122-24-001750
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112224001750/0001731122-24-001750-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112224001750/e6107_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-24-001750
- JSON: https://secwatch.observer/filing/0001731122-24-001750.json
- Plain text: https://secwatch.observer/filing/0001731122-24-001750.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.